What concrete financial impact did Trump's executive order have on psychedelic drug companies, according to the news?

According to the news, Enveric Biosciences raised $5 million immediately following the announcement of Trump's executive order, and Optimi Health reported a surge in investor calls seeking sector understanding; however, most companies stated that new funding remains 'just a hope' and researchers emphasized that costly, time-consuming clinical development still lies ahead, with most psychedelic drugs still in early stages and far from market approval.

How do investors and executives expect the executive order to change regulatory timelines and investor participation in the psychedelic drug sector?

Executives and investors expect the order to shorten administrative timelines and improve coordination between the FDA and DEA, potentially compressing some FDA review periods from 10–12 months to just 1–2 months—saving clinical-stage companies 'tens of millions of dollars'; additionally, the order is seen as reducing regulatory uncertainty, which may attract institutional investors like sovereign wealth funds and public pension plans who had previously stayed on the sidelines, though benefits are expected to accrue first to late-stage developers with breakthrough therapy designations or pivotal data.

Trump's Psychedelic Drug Order Boosts Investor Interest with Promise of Faster Reviews

May 18, 2026

U.S. President Trump issued an executive order to accelerate psychedelic drug development, aiming to shorten FDA review timelines and improve DEA coordination. Investors anticipate reduced regulatory risk and funding, though researchers caution treatments remain in early stages.

reuters

2026-05-18

Trump's Psychedelic Drug Order Boosts Investor Interest with Promise of Faster Reviews

2026-06-30

Trump's Push for Lowest Drug Prices Hits Snag with Mid-Sized Companies

2026-09-19

Trump Announces All 50 States Joining Medicaid Drug Pricing Model

Trump's Psychedelic Drug Order Boosts Investor Interest with Promise of Faster Reviews

FAQ